Literature DB >> 3283191

Intermittent positive pressure ventilation by nasal mask: technique and applications.

N Carroll1, M A Branthwaite.   

Abstract

Intermittent positive pressure ventilation delivered non-invasively through a well-fitting nasal mask has been used to control nocturnal hypoventilation in three patients with severe, combined cardiorespiratory and skeletal disease. The advantages of this approach to domiciliary ventilation are described and the requirements of the ventilator are defined.

Entities:  

Mesh：

Year:  1988        PMID： 3283191     DOI： 10.1007/bf00257462

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


  4 in total

1.  Effects of protriptyline on sleep related disturbances of breathing in restrictive chest wall disease.

Authors:  A K Simonds; R A Parker; M A Branthwaite
Journal:  Thorax       Date:  1986-08       Impact factor: 9.139

Review 2.  Assisted ventilation at home: is it worth considering?

Authors:  W J Kinnear; J M Shneerson
Journal:  Br J Dis Chest       Date:  1985-10

3.  Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares.

Authors:  C E Sullivan; F G Issa; M Berthon-Jones; L Eves
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

4.  Sleep apnea considered as a control system instability.

Authors:  G S Longobardo; B Gothe; M D Goldman; N S Cherniack
Journal:  Respir Physiol       Date:  1982-12
  4 in total
  4 in total

1.  Assisted ventilation 6. Non-invasive and domiciliary ventilation: positive pressure techniques.

Authors:  M A Branthwaite
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

2.  Mechanical ventilation at home.

Authors:  M A Branthwaite
Journal:  BMJ       Date:  1989-05-27

3.  Non-invasive modalities of positive pressure ventilation improve the outcome of acute exacerbations in COLD patients.

Authors:  M Vitacca; F Rubini; K Foglio; S Scalvini; S Nava; N Ambrosino
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

4.  Neuromuscular disease, respiratory failure and cor pulmonale.

Authors:  J White; R E Bullock; P Hudgson; G J Gibson
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.